middle.news
Tissue Repair Navigates Phase 3 Trial Hurdles Amid US Market Shakeup
4:57am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Tissue Repair Navigates Phase 3 Trial Hurdles Amid US Market Shakeup
4:57am on Monday 2nd of June, 2025 AEST
Key Points
Phase 3 trial enrollment slow with only 4 patients randomized to date
Regulatory changes in US wound care market increasing clinical trial competition
TR Pro+® sales reach record high in March with orders from over 300 clinics
Glucoprime® API manufacturing scale-up underway to support growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tissue Repair (ASX:TRP)
OPEN ARTICLE